Statistics
The Obsidian Therapeutics stock price is currently $ 12.56 with a total market cap valuation of $ 13.06M (1.04M shares outstanding). The Obsidian Therapeutics is trading on NASDAQ under the ticker sign OBX. Obsidian Therapeutics price is up
Description
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.
Company Profile
- Full Name: Obsidian Therapeutics
- Sector: Healthcare
- Website: https://www.obsidiantx.com
